INIS
drugs
100%
brain
79%
nanoparticles
75%
bacteria
66%
toxicity
59%
cysts
56%
host
54%
genotype
51%
pathogens
46%
molecules
44%
humans
44%
environment
42%
central nervous system
41%
diseases
39%
water
32%
in vitro
31%
cancer
31%
amoeba
31%
silver
30%
encephalitis
29%
human cells
29%
lenses
29%
animals
29%
viability
26%
pathogenesis
25%
Pharmacology, Toxicology and Pharmaceutical Science
Amoeba (Life Cycle Stage)
80%
Antiinfective Agent
60%
Infection
49%
Acanthamoeba castellanii
48%
Acanthamoeba
41%
Naegleria fowleri
38%
Nanoparticle
33%
Antiamoebic
31%
Silver Nanoparticle
30%
Cytotoxicity
28%
Balamuthia mandrillaris
24%
Antibacterial Activity
23%
Infectious Agent
22%
Intestine Flora
21%
Primary Amebic Meningoencephalitis
20%
Immunology and Microbiology
Acanthamoeba
85%
Acanthamoeba castellanii
62%
Cytotoxicity
41%
Infectious Agent
34%
Naegleria fowleri
25%
Trophozoite
24%
Intestine Flora
24%
Host Cell
23%
Balamuthia mandrillaris
23%
Escherichia coli
20%